Grant Details

General Overview

Grant Information

Grant name: Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders

Funding organization: National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Total funding amount: Up to $125,000 per year for R21 phase; up to $250,000 per year for R33 phase

Duration: R21 phase up to 2 years; R33 phase up to 3 years; total project period not exceeding 5 years

Primary objective: Support projects that functionally validate and/or characterize genes or variants involved in substance use disorders

Funding source: Federal government

Significance: Addresses critical gaps in understanding the neurobiological mechanisms of addiction

Grant frequency: Recurring

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits (with and without 501(c)(3) status)

For-Profit Organizations (including Small Businesses)

Local, State, County, City Governments

Indian/Native American Tribal Governments (both Federally Recognized and not)

Federal Government Agencies

U.S. Territories

Other entities including Independent School Districts, Public Housing Authorities, Faith-based Organizations, and Foreign Organizations

Specific Qualifications

Organizations must complete registrations with SAM, eRA Commons, and Grants.gov prior to application submission

All Principal Investigators must have an eRA Commons account

Scope and Focus

Primary Focus Areas

Functional validation and characterization of addiction-relevant genes or variants

Research must include exposure to addictive substances relevant to NIDA

Target Beneficiaries

Research teams with expertise in substance use disorder (SUD) relevant science

Technical Details

Technical Expertise Requirements

Research teams should demonstrate capability in proposed techniques or assays

No preliminary data required, but justification based on scientific literature is necessary

Financial Structure

Budget Limitations

R21 phase budget cannot exceed $125,000 per year

R33 phase budget cannot exceed $250,000 per year

Timeline and Implementation

Key Dates

Open Date: February 3, 2025

Application Due Date: July 28, 2025

Earliest Start Date: March 3, 2025

Compliance and Requirements

Regulatory Compliance

Must adhere to NIH Grants Policy Statement and federal regulations

No cost sharing required

Application Process

Submission Requirements

Applications must be submitted electronically via Grants.gov

Letter of Intent is encouraged but not required

Grant Details

substance use disorder genetics biomedical research healthcare drug addiction research funding NIH NIDA
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders
PAR-24-267
NIH Grants
EDU NGO ENTERPRISE PUBLIC RESEARCH OTHER
US
HEALTHCARE OTHER
DEVELOPMENT OTHER
0-10 11-50 51-250 251-500 500+
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
None
125000.00
250000.00
USD
None
July 28, 2025, 10 p.m.
Not specified